Amgen

Amgen Inc., a pioneer in the biotechnology sector, was founded in 1980 as Applied Molecular Genetics and is headquartered in Thousand Oaks, California. Operating under the ticker NASDAQ: AMGN, the company has established itself as a leading American multinational biotechnology firm. Amgen is dedicated to discovering, developing, manufacturing, and delivering innovative human therapeutics. Its core focus lies in leveraging cutting-edge science and technology to address serious illnesses and improve patient outcomes across various therapeutic areas, including oncology, hematology, cardiovascular disease, and bone health. The company's commitment to scientific advancement drives its mission to serve patients by transforming the promise of science and biotechnology into therapies that have the potential to restore health or save lives.

With a significant operational footprint, Amgen maintains 40 locations globally, underscoring its extensive reach and capacity for large-scale biopharmaceutical production and distribution. The company employs over 10,000 individuals, forming a robust team dedicated to its mission. Learn about Amgen's global headquarters for detailed information on its primary operational hub. The expertise and dedication of its workforce are critical to Amgen's success in developing complex biological medicines. Meet Amgen's team to understand the leadership and talent driving its innovation pipeline and global operations.

Amgen reported substantial revenue of $37.2 billion, reflecting its strong market position and the commercial success of its product portfolio. The company's product offerings span a range of critical medical needs, including biopharmaceuticals and human therapeutics for conditions like cancer and cardiovascular disease. Amgen actively engages in strategic partnerships and has secured significant funding, includingView more...